myBiometry

myBiometry is developing a breath test and digital solution to monitor airway inflammation in asthma and COPD patients. The data helps identify risk of attack up to 20 days before symptoms. If you would like to support how we are transforming the lives of patients and caregivers for Asthma and COPD, please consider: - Watch our 1-minute video and hit LIKE on YouTube 👍 - Share it with your connections to spread the word! 👪 - Get in touch with us to help with our mission to prevent asthma attacks 🤙 We are thrilled to be included in the 2024 Cohort for MedTech Innovator accelerator. By watching our 1-minute video and liking us on YouTube you will also be supporting us to win MedTech Innovator Best Video. #asthma #copd #healthcareinnovation #endasthmaattacks Asthma and Allergy Foundation of America Global Initiative for Asthma American Medical Association American Lung Association American Thoracic Society AdvaMed MassChallenge UMassM2D2 MedTech Innovator

At myBiometry, our mission is to empower individuals to take control of their asthma and COPD proactively with our technology and personalized solutions. We are committed to transforming asthma and COPD management with our movement from episodic to continuous data. Next week, we're thrilled to announce that Bryan Nolan, our Chief Executive Officer, and Anmol Wassan, our Chief Operating Officer, will be attending @JPM Healthcare Week 2025 in San Francisco! This is an incredible opportunity to connect with us, discuss innovations in healthcare, and explore potential collaborations. Whether you're passionate about health tech, curious about our vision, or looking for ways to partner, we'd love to meet you. 📅 Dates: Monday, January 13 – Thursday, January 16 📍 Location: San Francisco Let’s make health innovation happen together! Schedule a time to connect with Bryan and Anmol. Visit www.mybiometry.com to learn more about our work. #JPMHealth2025 #HealthcareInnovation #HealthTech #Networking

P.S.A: Different types of asthma inhalers. A guide from Asthma and Allergy Foundation of America. #respiratoryhealth

Our CEO, Bryan Nolan, recently had the opportunity to speak with Holly Scott from The Mullings Group about the "reactive" approach of symptom based management in asthma today. Traditional asthma management hinges on three pillars: 1. Infrequent Pulmonary Function Tests (PFTs): Most asthma patients undergo PFTs only during occasional clinic visits. This episodic data fails to capture the day-to-day fluctuations in lung function, leaving providers to make treatment decisions based on a snapshot rather than a continuous picture. 2. Symptom Diaries and Patient Memory: Many asthma management plans rely on patients tracking their symptoms in journals or apps. However, these records are inherently subjective and prone to human error, leading to inaccuracies that undermine effective care. 3. One-Size-Fits-All Medication Plans: Asthma treatment often involves broad-spectrum medications prescribed with minimal customization. The result? Over-medication for some and under-treatment for others, contributing to preventable exacerbations, higher healthcare costs, and reduced quality of life. The current asthma management paradigm is not just inconvenient - it's dangerous and expensive. Asthma exacerbations lead to 2.5 million emergency department visits annually in the U.S. alone, costing billions of dollars and causing significant morbidity. Better data can dramatically reduce these numbers. With myBiometry, the asthma care model shifts from reactive to proactive, from generic to personalized, and from episodic to continuous. This isn’t just an incremental improvement—it’s a complete transformation of how we understand and manage asthma. Stay tuned for more insights from this inspiring conversation! #Innovation #Healthcare #Asthma #COPD #Biomarkers #PersonalizedMedicine

🚀 Exploring the Future of Personalized Medicine in Asthma and COPD Our CEO, Bryan Nolan, recently had the opportunity to speak with Holly Scott to discuss the transformative role of biomarkers in managing asthma and COPD. Their conversation delved into how these innovative biomarkers are reshaping disease management by enabling stratification and personalization for patients. With the power to identify each patient's risk of attack, these biomarkers are paving the way for more precise treatments, improved outcomes, and a new era in respiratory care. At myBiometry, we’re excited to be at the forefront of this evolution, driving innovation that truly puts patients first. Thank you to Holly Scott and her team to feature this important topic. Stay tuned for more insights from this inspiring conversation! #Innovation #Healthcare #Asthma #COPD #Biomarkers #PersonalizedMedicine #TechTalkspodcast

We’re thrilled to share that myBiometry's CEO, Bryan Nolan, will be presenting at the MedTech Strategist Innovation Summit in San Diego this week! myBiometry has been selected as a finalist for the 2024 MedTech Innovator Value Award, a tremendous honor recognizing impactful companies driving meaningful change in healthcare. If you're attending the conference, we’d love to connect and share how myBiometry is: ✴️ Empowering patients, providers, and caregivers with critical data to better manage asthma and COPD. ✴️ Helping payers reduce costs by preventing costly ER visits and ensuring patients receive the right treatments at the right time. The Value Award Competition will take place on Tuesday, November 19, at 4:40 p.m. Stop by or get in touch to learn more about our work and vision for improving respiratory health. We’re excited to continue our journey toward transforming patient care and to stand alongside other innovative companies shaping the future of MedTech. #MedTechStrategist #MedTechInnovator #myBiometry #Asthma #COPD #HealthcareInnovation #SanDiego

🌟 Exciting News: myBiometry’s Recent Fundraising Success! 🌟 We’re thrilled to announce that myBiometry has successfully completed our latest funding round! This support is a huge step forward in our mission to transform respiratory health management for asthma and COPD patients with predictive, at-home monitoring solutions. A big thank you to our investors and partners who believe in our vision and are helping us expand access to life-changing technology. We’re energized to drive the future of proactive healthcare! “We’re excited to partner with Dexcom's Venture Group and CareSource as we near the milestone of submitting fenoTRACK for regulatory clearance,” said Bryan Nolan, CEO of myBiometry. “With enhanced at-home monitoring for asthma and COPD, we strive to identify attack risks sooner, enabling clinicians to offer more personalized care and preventive interventions that lessen the burden on patients, caregivers, and healthcare payers.” For more details, read our latest update here: mybiometry.com/news #HealthTech #Innovation #Fundraising #myBiometry #RespiratoryCare #Asthma #COPD

🌟 Honored to Be a Finalist for the 2024 MedTech Innovator Value Award! 🌟 We’re thrilled to announce that myBiometry has been selected as a finalist for the MedTech Innovator 2024 Value Award! This recognition celebrates healthcare solutions that demonstrate strong value to patients, providers, and payers by lowering costs, improving outcomes, and driving accessible innovation. Being recognized among such impactful companies is a tremendous honor, and we’re excited to continue our journey toward making a difference in patient care. The Award competitions will take place during the MedTech Strategist Innovation Summit in San Diego, with the Value Award Competition taking place on Tuesday, November 19, at 4:40 p.m. Thank you, MedTech Innovator, for this opportunity! #MedTechInnovator #ValueAward #Innovation #Healthcare #MedTech #medicaldevice #MTS24

🚀 Inspired by Innovation: Reflections from The MedTech Conference 2024 Last week at The MedTech Conference 2024 in Toronto, our team came away inspired by the incredible advancements shaping the future of healthcare. Our CEO, Bryan Nolan, had the honor of speaking on a panel about Breathing and Sleeping, where he shared insights on how predictive health technologies can empower patients with respiratory conditions. Hearing AdvaMed’s CEO, Scott Whitaker, reflect on past innovations reminded us that the most transformative ideas often start as bold dreams. At myBiometry, we are committed to helping Asthma and COPD patients change the trajectory of their lives through proactive and predictive health data—and we hope our work will be among the breakthroughs Whitaker celebrates in the future. We were also inspired by the many remarkable advancements showcased in his keynote, such as: - From needles and blood draws to insulin pumps and continuous glucose monitors. - From open-heart surgeries to minimally invasive procedures. - Pacemakers shrinking from car batteries to nickel-sized devices. - Heart monitors evolving from bulky equipment to wearable patches that gather data over days. - And from people once told they would never walk again to now carrying the Olympic torch. The future of healthcare is here, and we are proud to be a part of this exciting journey, bringing innovative solutions to help patients breathe easier and live better. #MedTechCon #HealthcareInnovation #Asthma #COPD #PredictiveHealth #MedicalTechnology #myBiometry #Toronto #Inspiration #medtechinnovator